Skip to main content

AlphaCentric Advisors LLC

SEC CIK
0001913464
Latest filing
Jul 24, 2026

VRDN holding history

Viridian Therapeutics, Inc. in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRDN overviewAll 13F holders of VRDNFull Q2 2026 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
8
Since Q3 2022
Holdings of VRDN by AlphaCentric Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−15,000−100.0%Sold outHolders
Q3 202415,000$341.3K0.3%+2,500+20.0%AddedHolders
Q2 202412,500$162.6K0.1%+6,500+108.3%AddedHolders
Q1 20246,000$105.1K0.1%+6,000NewHolders
Q4 20230$00.0%−80,000−100.0%Sold outHolders
Q3 202380,000$1.23M0.7%+44,500+125.4%AddedHolders
Q2 202335,500$844.5K0.5%00.0%UnchangedHolders
Q1 202335,500$903.1K0.6%00.0%UnchangedHolders
Q4 202235,500$1.04M1.0%00.0%UnchangedHolders
Q3 202235,500$728.0K0.7%–No prior filingHolders